Lymphedema: another aspect in cutaneous leishmaniasis
Keywords:
Cutaneous leishmaniasis, secondary lymphedema.Abstract
Background Cutaneous leishmaniasis (CL) is a common parasitic disease of the skin. Ugly scarring is a common sequel of CL. We report lymphedema, another disfiguring complication, in our patients in this chronic illness. Objective The main objective of this study was to determine the incidence of secondary lymphedema in leishmaniasis of lower legs and feet. Patients and methods This study was conducted at multiple centers in Balochistan province of Pakistan from 1st Feb, 2008 to 12th Sep, 2008. Out of 1920 patients with CL examined over this duration, 567 patients having the disease on the lower legs and feet were recruited in the study. All these patients were assessed for the presence of lymphedema of the involved limbs while edema observed was sorted into mild, moderate and severe categories. Follow up period was six weeks in order to observe the outcome of this complication. Results Out of the total number of 1920 patients, 567 (29.5%) had leishmaniasis of the lower legs and feet and out of these 157(27.7%) patients developed lymphedema of the affected limbs. Among these 157 patients, 76(48.4%) had mild edema, 52 (33.1%) had moderate edema and 29 (18.5%) had severe edema. Over a six weeks follow up period edema persisted in 43% of the patients inspite of successful treatment of CL with injectable antimony therapy. Conclusion Cutaneous leishmaniasis can lead to lymphedema of the lower legs and feet and has to be considered while enlisting the causes of secondary lymphedema.ÂReferences
Stark CG. Leishmaniasis. eMedicine (Last updated March 27, 2008) Available at: http://www.medscape.com/article/220298-overview (Accessed on October 10, 2008).
Stebut EV. Immunology of cutaneous leishmanisis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Europ J Dermatol 2007; 17: 115-22.
Zakai HA, Zimmo Sameer KH, Mahmoud FAH et al. Effect of itraconazole and terbinafine on Leishmania promastigotes. J Egypt Soc Parasitol 2003; 33: 97-107.
Momeni AZ, Aminjavaeri M. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol. Europ J Dermatol 2003; 13: 40-3.
Al-Wakeel M, Kiehl P, Kapp A et al. Cutaneous leishmaniasis (Aleppo boil) successful treatment with topical paromomycin (Humatin®). Europ J Dermatol 1997; 7: 47-8.
Hsia RY. Leishmaniasis. eMedicine (Last updated march 31, 2008) Available at: http://emedicine.medscape.com/article/783750-overview (Accessed on October 14, 2008).
Vega-Lopez F, Hay RJ. Leishmaniasis. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook’s Textbook of Dermatology, 7th edn. London: Blackwell Science; 2004. p. 32.35-47.
Myint C K, Asato Y, Yamamoto Y et al. Molucular Parasitilogy. In: Hashiguchi H, ed. Studies on New and Old World Leishmaniasis and their Transmission, with Particular reference to Ecuador, Peru, Argentina and Pakistan. Research Report Series 2007; 8: 11-27.
Gardener PJ, Shchory L. Chance ML. Species differentiation in the genus leishmania by morphometric studies with the electron microscope: Part 1. Ann Trop Med Parasitol 1977; 71: 147-56.
Shamsuddin S, Mengal JA, Gazozai S et al. Atypical presentation of cutaneous leishmaniasis in the native population of Balochistan. J Pak Assoc Dermatol 2006; 16: 196-200.
Turpie AG. Lymphedema. The Merck Manual of Patient Symptoms (last updated March 2008) Available at: http://www.merck.com/mmpe/sec07/ch081h.html (Accessed on Oct 13, 2008).
